For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of CME Group Inc (NASDAQ: CME) closed at $281.46 in the last session, up 0.21% from day before closing price of $280.87. In other words, the price has increased by $0.21 from its previous closing price. On the day, 0.88 million shares were traded. CME stock price reached its highest trading level at $283.06 during the session, while it also had its lowest trading level at $280.69.
Ratios:
We take a closer look at CME’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.85. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 25, 2025, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $300. UBS Downgraded its Buy to Neutral on July 24, 2025, while the target price for the stock was maintained at $305.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Sammann Derek sold 7,200 shares for $275.67 per share. The transaction valued at 1,984,798 led to the insider holds 7,022 shares of the business.
Sammann Derek bought 7,200 shares of CME for $1,979,928 on Nov 20 ’25. On Nov 03 ’25, another insider, Ford Harold Eugene Jr., who serves as the Director of the company, sold 1,000 shares for $263.53 each. As a result, the insider received 263,530 and left with 1,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 101494407168 and an Enterprise Value of 102693912576. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.28, and their Forward P/E ratio for the next fiscal year is 24.22. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.87 while its Price-to-Book (P/B) ratio in mrq is 3.59. Its current Enterprise Value per Revenue stands at 16.083 whereas that against EBITDA is 22.851.
Stock Price History:
The Beta on a monthly basis for CME is 0.28, which has changed by 0.1946013 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $224.62. The 50-Day Moving Average of the stock is 4.16%, while the 200-Day Moving Average is calculated to be 4.50%.
Shares Statistics:
According to the various share statistics, CME traded on average about 1.92M shares per day over the past 3-months and 2251820 shares per day over the past 10 days. A total of 359.85M shares are outstanding, with a floating share count of 359.05M. Insiders hold about 0.43% of the company’s shares, while institutions hold 90.94% stake in the company. Shares short for CME as of 1763078400 were 5410273 with a Short Ratio of 2.82, compared to 1760486400 on 4493938. Therefore, it implies a Short% of Shares Outstanding of 5410273 and a Short% of Float of 1.5.
Dividends & Splits
The forward annual dividend rate for CME is 4.87, which was 4.9 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.017445793. The stock’s 5-year Average Dividend Yield is 3.47. . The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-09-09 with an ex-dividend date of 2025-12-12. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
The stock of CME Group Inc (CME) is currently drawing attention from 12.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $2.9, with high estimates of $3.09 and low estimates of $2.72.
Analysts are recommending an EPS of between $11.29 and $10.98 for the fiscal current year, implying an average EPS of $11.13. EPS for the following year is $11.63, with 15.0 analysts recommending between $12.38 and $11.15.
Revenue Estimates
According to 7 analysts, . The current quarter’s revenue is expected to be $1.62B. It ranges from a high estimate of $1.69B to a low estimate of $1.53B. As of . The current estimate, CME Group Inc’s year-ago sales were $1.53BFor the next quarter, 7 analysts are estimating revenue of $1.67B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.61B.
A total of 13 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.62B, while the lowest revenue estimate was $6.4B, resulting in an average revenue estimate of $6.5B. In the same quarter a year ago, actual revenue was $6.13BBased on 13 analysts’ estimates, the company’s revenue will be $6.8B in the next fiscal year. The high estimate is $7.14B and the low estimate is $6.57B.
